Atlas Trials

Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL

Clinical trial NCT01305655 · COMPLETED

Trial details

NCT number
NCT01305655
Sponsor
Nordic Society for Pediatric Hematology and Oncology
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia (ALL)
Start date
2008-07-01
Primary completion
2014-12-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.